Evidence linking alcohol to cancer has accumulated for years, yet less than half of Americans recognize it as a cancer risk factor ...

Participation in the 340B Drug Pricing Program does not increase the use of targeted therapy in older patients with advanced prostate cancer, a study suggests.

(HealthDay News) — Exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) during pregnancy is associated with an increased risk for childhood chronic kidney disease (CHD), although the association ...

Modest absolute reduction in use observed, which increased during peak of shortage; no difference seen in mortality during shortage ...

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) frequently detects metastatic disease missed by conventional imaging, investigators report.

Seasonal influenza vaccination, but not COVID-19 vaccination, in patients with acute heart failure is associated with less severe decompensation.

“Mortality prediction models for people with kidney failure can support patient-clinician discussions at a crucial point where decisions are made about treatment options, including long-term kidney ...

(HealthDay News) — Racial and ethnic disparities are seen in the use of obesity-management medications, according to a study published online in the Journal of Racial and Ethnic Health Disparities.

The FDA has issued a CRL to Lexicon regarding the NDA for Zynquista (sotagliflozin) as an adjunct to insulin therapy for T1D and CKD.

The FDA has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), a new subcutaneous injection formulation of Opdivo.

Intensive blood pressure control in hypertensive chronic kidney disease (CKD) provides a survival advantage and other benefits.

Acellular tissue-engineered vessel is approved for use in adults as a vascular conduit for extremity arterial injury ...